Open Interest and Volume Dynamics
On 3 July 2026, Apollo Hospitals (symbol: APOLLOHOSP) recorded an open interest (OI) of 31,933 contracts, marking a robust increase of 3,633 contracts or 12.84% compared to the previous OI of 28,300. This rise in OI is accompanied by a volume of 27,844 contracts, indicating strong trading activity in the derivatives market. The futures segment alone accounted for a value of approximately ₹19,589.17 lakhs, while options contributed an overwhelming ₹29,395.20 crores, culminating in a total derivatives value of ₹23,270.21 lakhs.
The underlying stock price closed at ₹8,891, having hit a new 52-week high of ₹8,918 intraday, reflecting a 2.55% gain on the day. This price appreciation outperformed the hospital sector’s 1.15% gain and the Sensex’s 0.68% rise, underscoring Apollo Hospitals’ relative strength within its industry and the broader market.
Market Positioning and Technical Indicators
Apollo Hospitals has been on a positive trajectory, gaining for two consecutive days with a cumulative return of 3.13%. The stock is trading above all key moving averages – 5-day, 20-day, 50-day, 100-day, and 200-day – signalling a sustained bullish trend. Despite this, investor participation in terms of delivery volume has declined sharply, with a 58.27% drop against the five-day average delivery volume, registering 93.89k shares on 2 July. This divergence between price strength and falling delivery volumes may indicate increased speculative activity in the derivatives market rather than outright accumulation in the cash segment.
Interpreting the Open Interest Surge
The sharp rise in open interest alongside rising prices and volumes typically suggests fresh long positions being established, reflecting bullish sentiment among traders. The 12.84% increase in OI is significant for a large-cap stock like Apollo Hospitals, which boasts a market capitalisation of ₹1,27,184 crores. This surge may be driven by institutional investors or sophisticated traders positioning for further upside, anticipating continued sectoral growth and company-specific catalysts.
Moreover, the futures value of nearly ₹19,589 lakhs indicates substantial capital deployment in the derivatives segment, while the options market’s massive ₹29,395 crore valuation points to active hedging and speculative strategies. The combined derivatives turnover of over ₹23,270 lakhs highlights the stock’s liquidity and attractiveness for traders seeking leveraged exposure.
Perfect timing to enter! This Small Cap from IT - Software just turned profitable with growth momentum clearly building up. Get in before the broader market notices!
- - New profitability achieved
- - Growth momentum building
- - Under-the-radar entry
Sectoral Context and Relative Performance
The hospital sector has been underpinned by steady demand for healthcare services, with Apollo Hospitals positioned as a market leader. The stock’s outperformance relative to the sector and Sensex on 3 July reflects investor preference for quality large caps amid ongoing economic recovery and healthcare spending growth. Apollo’s mojo score of 78.0, upgraded from a previous Hold to a Buy rating on 11 May 2026, further reinforces its favourable outlook.
Trading above all major moving averages confirms the stock’s technical strength, while the recent price surge to a new 52-week high signals renewed investor optimism. However, the decline in delivery volumes suggests that the price gains may be driven more by short-term trading interest than long-term accumulation, warranting cautious monitoring of market participation trends.
Potential Directional Bets and Investor Implications
The increase in open interest, coupled with rising prices and volumes, points to a directional bet favouring further upside in Apollo Hospitals. Traders appear to be establishing fresh long positions, possibly anticipating positive earnings, sector tailwinds, or strategic developments. The derivatives market activity also suggests that investors are employing options strategies to hedge or leverage their exposure, reflecting a nuanced approach to risk management.
Given the stock’s large-cap status and liquidity profile, with a tradable size of approximately ₹5.55 crores based on 2% of the five-day average traded value, Apollo Hospitals remains an attractive candidate for both institutional and retail investors seeking exposure to the healthcare sector’s growth story.
Want to dive deeper on Apollo Hospitals Enterprise Ltd.? There's a real-time research report diving right into the fundamentals, valuations, peer comparison, financials, technicals and much more!
- - Real-time research report
- - Complete fundamental analysis
- - Peer comparison included
Outlook and Strategic Considerations
With a mojo grade upgraded to Buy and a strong mojo score of 78.0, Apollo Hospitals is well positioned to capitalise on the expanding healthcare demand in India. The recent open interest surge in derivatives markets signals growing conviction among traders about the stock’s upside potential. However, investors should remain vigilant about the divergence between price gains and falling delivery volumes, which may indicate speculative positioning rather than broad-based accumulation.
Long-term investors may view the current momentum as an opportunity to add to positions, supported by the company’s robust fundamentals and sector leadership. Meanwhile, traders can monitor open interest and volume patterns closely to gauge shifts in market sentiment and adjust strategies accordingly.
Summary
Apollo Hospitals Enterprise Ltd. has demonstrated a notable increase in open interest by 12.84%, accompanied by strong volume and price appreciation to a new 52-week high. The stock’s outperformance relative to its sector and the Sensex, combined with its upgraded mojo rating, underscores a positive market outlook. While delivery volumes have declined, the derivatives market activity suggests fresh bullish bets and strategic positioning. Investors and traders alike should consider these dynamics when evaluating Apollo Hospitals as part of their portfolio or trading strategies.
Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today
